CAMPBELL & CO INVESTMENT ADVISER LLC Halozyme Therapeutics, Inc. Transaction History

CAMPBELL & CO INVESTMENT ADVISER LLC portfolio value:

$819,000
portfolio value

CAMPBELL & CO INVESTMENT ADVISER LLC quarter portfolio value change:

-10.14%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +26.81% 4.38K shares 100K $39.54 20.72K
Q2 2022 share Increase 0.00% 16.34K shares 719K $44 16.34K
Q4 2021 share Decrease -100.00% -11.06K shares -450K $40.32 0
Q3 2021 share Increase 0.00% 11.06K shares 450K $40.68 11.06K
Q2 2021 share Decrease -100.00% -5.81K shares -242K $45.41 0
Q1 2021 share Increase +15.95% 800 shares 28K $41.69 5.81K
Q4 2020 share Decrease -56.45% -6.5K shares -89K $42.71 5.01K
Q3 2020 share Decrease -22.64% -3.36K shares -96K $26.28 11.51K
Q2 2020 share Increase 0.00% 14.88K shares 399K $26.81 14.88K
Q1 2020 share Decrease -100.00% -113.95K shares -2.02M $17.99 0
Q4 2019 share Increase 0.00% 113.95K shares 2.02M $17.73 113.95K